Gillette India Ltd.

NSE: GILLETTE
NIFTY500
₹7,641.50-26.3%1Y
Last updated 03:58:33 IST· Public market feed (~15 min delay during market hours)

Gillette India Ltd.: A 30-second snapshot

Gillette India trades at ₹7,590, down 26.26% over the past 12 months and 31.01% below its 52-week high, sitting below both its 50-day (₹7,794.92) and 200-day (₹8,076.82) moving averages with an RSI of 40.74. The company carries near-zero debt (D/E 0.002), a reported ROE of 66.44% and 5-year earnings growth of 21.3%, though 5-year revenue growth has been slower at 3.2%. Q1 FY27 results released on 2026-07-30 showed profit up roughly 9% and revenue up roughly 11% YoY, at a PE of 46.24x, close to the sampled FMCG peer median (~46.58x).

P/E

46.2

Forward P/E

ROE

+66.4%

Debt / Equity

0.00

Profit Margin

+21.1%

Div. Yield

+1.5%

5Y ROE > 15%

3/5

5Y FCF > 0

3/5

Quality

64/100

Recent context

  • ·Gillette India reported Q1 FY27 results on 2026-07-30: profit up ~9% YoY and revenue up ~11% YoY per Business Standard and Sahi.
  • ·CNBC-TV18 reported the stock fell on results day, attributing it to operating income growth trailing revenue growth.
  • ·Of the 8 most recent news items, 5 were tagged positive, 2 neutral and 1 negative, with the sampled headlines clustered on 2026-07-30 around the earnings release.

Strengths

  • +ROE of 66.44% is the highest among the sampled FMCG peer set (HUL, ITC, Nestle India, Tata Consumer, Britannia), alongside a quality score of 59 that ranks 1st of 6 in the sector.
  • +Debt-to-equity of 0.002 with a falling debt trend and 3 consecutive years of positive free cash flow.
  • +PE of 46.24x is close to the FMCG peer median (~46.58x) and below Nestle India (75.44x), Tata Consumer (65.90x) and Britannia (50.97x).
  • +Q1 FY27 results (reported 2026-07-30) showed revenue up ~11% and profit up ~9% YoY, with 5 of the 8 most recent news items tagged positive.

Weaknesses

  • Stock is down 26.26% over 12 months and trades 31.01% below its 52-week high, below both the 50-day (₹7,794.92) and 200-day (₹8,076.82) SMAs.
  • 5-year revenue growth of 3.2% trails both the 46.24x PE multiple and the 21.3% 5-year earnings growth rate, implying earnings gains have leaned more on margin or other factors than on topline expansion.
  • A CNBC-TV18 headline on the Q1 FY27 print specifically attributed the stock's results-day decline to operating income growth running slower than revenue growth.
  • No analyst rating or coverage count is available in the current dataset, limiting external benchmarking of consensus views.

Open questions

  • ?Does the gap between 21.3% five-year earnings growth and 3.2% five-year revenue growth reflect durable margin or cost efficiency, or a temporary earnings tailwind?
  • ?What is driving the divergence between Gillette India's sector-leading ROE and quality-score profile and its 26.26% price decline over the past 12 months?
  • ?How does the operating-income-versus-revenue growth gap flagged in the Q1 FY27 results compare with prior quarters — is margin pressure a new or recurring pattern?
  • ?With the stock trading close to its FMCG peer-median PE (46.24x vs ~46.58x) despite recent price weakness, what factors would need to hold for that relationship to persist or shift?

Peer comparison: FMCG

Ranks 1 of 6 on quality
SymbolNameP/EROEQuality
GILLETTEGillette India Ltd.You're viewing46.2+66.4%59
Industry avgacross 5 peers51.3+41.3%47
NESTLEINDNestle India Ltd.75.457
BRITANNIABritannia Industries Ltd.51.0+53.3%50
TATACONSUMTata Consumer Products Ltd.65.945
HINDUNILVRHindustan Unilever Ltd.46.944
ITCITC Ltd.17.1+29.3%41

Technical state

Current price

₹7,590.00

SMA 50

₹7,794.92

SMA 200

₹8,076.82

RSI (14)

40.7 (neutral)

From 52w high

-31.0%

1Y return

-26.3%

3M return

-4.6%

50-DMA

Below

200-DMA

Below

Algorithmic support levels

₹7,500.50
₹7,206.00

Algorithmic resistance levels

₹7,971.00
₹8,014.50
₹8,165.00

Risk flags

  • medium
    Price (₹7,590) is 6.0% below the 200-day SMA (₹8,076.82) and 2.6% below the 50-day SMA (₹7,794.92), 31.01% below its 52-week high, and down 26.26% over the past 12 months (RSI 40.74, neutral).
  • medium
    PE of 46.24x sits well above 5-year revenue growth of 3.2%, while 5-year earnings growth of 21.3% has run far ahead of revenue growth — earnings gains appear to lean more on margin or other factors than on topline expansion.
  • low
    No analyst rating or coverage count is present in the dataset, so external consensus benchmarking is not available for this stock.
  • low
    All 5 sampled recent headlines are dated 2026-07-30 and cluster around the Q1 FY27 results release; the 8-article sample may not reflect the fuller range of business or regulatory developments.

Cross-section contradictions

  • ROE of 66.44% (highest among the 6-company FMCG peer set), D/E of 0.002 and 3 consecutive years of positive free cash flow sit alongside a 26.26% decline over 12 months and a 31.01% drawdown from the 52-week high — a divergence between balance-sheet/profitability metrics and price trend.
  • Q1 FY27 results (2026-07-30) showed revenue up ~11% and profit up ~9% YoY with 5 of 8 recent headlines tagged positive, yet a CNBC-TV18 headline attributes a same-day stock decline to operating income growth running slower than revenue growth — the market reaction to the print was not uniformly positive despite the headline growth numbers.

For informational purposes only. Not investment advice. VivaTrades is not a SEBI-registered Investment Adviser or Research Analyst. Market data sourced from public feeds; consult a registered adviser before any investment decision.

Fundamentals & technicals: refreshed 11 Aug 2026 · refreshed daily at 01:00 IST

AI synthesis (narrative, snapshot, strengths/weaknesses, peer ranking): generated 31 Jul 2026 · rotates through NIFTY 500 every ~5 days